Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–3 of 3 results
Advanced filters: Author: Laura Furstenthal Clear advanced filters

  • Specialty pharmaceuticals — drugs prescribed primarily by specialists rather than primary-care physicians — have become an increasingly important part of the global pharmaceutical landscape. Ma and colleagues analyse the key factors influencing the commercial success and failure for specialty pharmaceuticals.

    • Mark Gudiksen
    • Edd Fleming
    • Philip Ma
    Reviews
    Nature Reviews Drug Discovery
    Volume: 7, P: 563-567

  • Although the potential of 'personalized medicine' to increase the quality of clinical care and decrease health-care costs has been recognized for many years, only a handful of associated diagnostic tests have made it to market so far, with mixed success. This article proposes that the major challenges to the further adoption of personalized medicine are increasingly related to economics, and discusses strategies that could help address these challenges.

    • Jerel C. Davis
    • Laura Furstenthal
    • Philip Ma
    Reviews
    Nature Reviews Drug Discovery
    Volume: 8, P: 279-286